Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by BuyingNowon Jul 30, 2016 5:11pm
99 Views
Post# 25098623

RE:RE:RE:RE:RE:RE:RE:Donnatal Efficacy?

RE:RE:RE:RE:RE:RE:RE:Donnatal Efficacy?The letters from the fda to cancodia on this fda regulations site could have easily been fabricated. Also the letter from Cancordias lawyer.  I don't believe that this drug is not fda approved fully and I don't believe that the fda requested this if they did I'm sure that the ceo would have handled it properly.  It is only one drug out of hundreds anyways.


LatticeInExiIe wrote: adamchess, Here is the article that summarizes why Donnatal is at risk. The author has sourced the article with letters from the FDA, as well as letters from Concordia's lawyers as a response, as well as numerous other documents explaining that the drug is up for DESI review.  Please refrain from saying that this is made up by the shorts because you will just look like a silly investor who doesn't do their due diligence.  If posters continue saying that this risk is made up without offering any substantial support for their claim, I will continue to post this seeking alpha article throughout the weekend.  

https://seekingalpha.com/instablog/47547305-the-capitolist/4903656-concordia-international-key-us-product-donnatal-extreme-regulatory-risk-may-put-business-risk


adamchess wrote: Why is Concordia being asked about the efficiency of Donnatel when this product has existed for ages? Surely, it has been found to significantly benefit customers or it would have been tossed out years ago. The whole attack by shorts makes no sense. Sales force was increased recently to boost sales of this product.




<< Previous
Bullboard Posts
Next >>